Abstract
Prostate cancer is the second most common cause of male cancer deaths in the UK. It is one of the few hormone-sensitive cancers and androgen ablation produces subjective and objective tumour regression in 70-80% of patients for a variable period. Orchidectomy remains the gold standard for treatment although there is an increasing number of equally effective medical alternatives.
Original language | English |
---|---|
Pages (from-to) | 710-715 |
Number of pages | 6 |
Journal | British Journal of Hospital Medicine |
Volume | 49 |
Issue number | 10 |
Publication status | Published - 19 May 1993 |
Externally published | Yes |